Abstract:Objective To study the relationship between the chemokine CX3CL1/ CX3CR1 and platinum drug resistance, as well as prognosis in ovarian cancer patients. To dynamically detect the resistance nude mice model of CX3CL1 and its receptor CX3CR1 in the course of platinum resistance. To analyze the expression of CX3CL1, CX3CR1 and the correlation of Fas signaling pathway. Methods The cancer gene atlas(TCGA) database of patients with ovarian cancer genome-wide expression was employed to analyze the relation-ship of CX3CL1/ CX3CR1 in platinum sensitivity or resistant patients with clinical features. Ovarian cancer SKOV3 sensitive cells(SK-OV3-GFP) with green fluorescent marker and cisplatin resistant cells(SKOV3-GFP / DDPⅢ) were subcutaneously injected in nude mice. After xenograft was constracted, cisplatin was intraperitoneally injected. Real time fluorescence quantitative-PCR(qRT-PCR) was used to detect the expression of CX3CL1, CX3CR1 and genes on Fas signal pathway after 0, 2, 5, 8 times of cisplatin injection. Results CX3CL1 expression was negatively correlated with FIGO and platinum resistance(r=-0. 112,P= 0. 030;r=-0. 106,P= 0. 044), CX3CR1 expression was negatively correlated with progression-free survival time(r = -0. 130,P = 0. 029) and positively correlated with 1-year re-lapse rate(r= 0. 119,P = 0. 045). The average expression of CX3CL1 in platinum sensitive group was 3. 96±0. 039, higher than 3. 64± 0. 55 of platinum resistant group(P= 0. 000). After the intervention of cisplatin, xenograft grew gradually. The weight of xenograft in SK-OV3-GFP / DDPⅢ group was higher than SKOV3-GFP group, and xenograft in the both two groups shrank at the fifth time of infection. After cisplatin stimulation, the expression of CX3CL1/ CX3CR1 in SKOV3-GFP group increased significantly(P= 0. 001, P= 0. 002), but it remained low in SKOV3-GFP / DDPⅢ group. The expression of Fas and FADD of Fas signal pathway in SKOV3 GFP / DDPⅢ group was also significantly lower than them in SKOV3-GFP group(P<0. 001). However, PARP1 gene significantly rose in SKOV3GFP / DDPⅢgroup than that in SKOV3-GFP group(P<0. 001). The expression of CX3CL1 and CX3CR1 was positively correlated with Fas and FADD, while it was negatively correlated with PARP1 of Fas signaling pathways. Conclusion The down-regulation of CX3CL1 and CX3CR1 is associated with platinum resistance. They may play a role in maintain the sensitivity of tumor cells to platinum. The low expression of CX3CL1 and CX3CR1 may suppress Fas signal pathway through some mechanism, resulting in transduction disorder, inhibiting cell apop-tosis and inducing platinum resistance of ovarian cancer. The lower expression of drug-resistant cells may be a mechanism inhibiting Fas signaling pathways, which make its conduction misbalance, finally inhibiting cell apoptosis, inducing the resistance of ovarian cancer. It may be a platinum promote ovarian cancer therapy targeting molecules.

Low Concentration Of Quercetin Antagonizes The Cytotoxic Effects Of Anti-Neoplastic Drugs In Ovarian Cancer

Effects of Quercetin on the Efficacy of Various Chemotherapeutic Drugs in Cervical Cancer Cells

Potentiation of Cisplatin Cytotoxicity in Resistant Ovarian Cancer SKOV3/Cisplatin Cells by Quercetin Pre-Treatment

The impact of quercetin and paclitaxel combination on ovarian cancer cells

Induction of Apoptosis and Inhibition of Angiogenesis by PEGylated Liposomal Quercetin in Both Cisplatin-Sensitive and Cisplatin-Resistant Ovarian Cancers

Quercetin attenuates metastatic ability of human metastatic ovarian cancer cells via modulating multiple signaling molecules involved in cell survival, proliferation, migration and adhesion

Chemokine CX3CL1/CX3CR1 biological axis promote ovarian cancer cell apotosis induced by platinum drug

Effect of quercetin on the anti-tumor activity of cisplatin in EMT6 breast tumor-bearing mice

Suppression of the Antioxidant System and PI3K/Akt/mTOR Signaling Pathway in Cisplatin-Resistant Cancer Cells by Quercetin

Anticancer Effect and Mechanism of Polymer Micelle-Encapsulated Quercetin on Ovarian Cancer.

Impact of quercetin on autophagy and apoptosis induced by a high concentration of CuSO4 in porcine ovarian granulosa cells

Clarithromycin Synergizes with Cisplatin to Inhibit Ovarian Cancer Growth in Vitro and in Vivo

Chemotherapy impairs ovarian function through excessive ROS-induced ferroptosis

Combination of quercetin and cisplatin enhances apoptosis in OSCC cells by downregulating xIAP through the NF-κB pathway

Efficacy of Quercetin and Quercetin Loaded Chitosan Nanoparticles Against Cisplatin-Induced Renal and Testicular Toxicity via Attenuation of Oxidative Stress, Inflammation, and Apoptosis

Quercetin alleviates cyclophosphamide-induced premature ovarian insufficiency in mice by reducing mitochondrial oxidative stress and pyroptosis in granulosa cells

Quercetin-Induced Glutathione Depletion Sensitizes Colorectal Cancer Cells to Oxaliplatin

Quercetin Mitigates Cisplatin-Induced Oxidative Damage and Apoptosis in Cardiomyocytes through Nrf2/HO-1 Signaling Pathway

Luteinizing Hormone Compromises the in Vivo Anti-Tumor Effect of Cisplatin on Human Epithelial Ovarian Cancer Cells.

Genistein and Cisplatin, Alone and in Combination, Suppress Growth of Human Ovarian Carcinoma Cell Line SKOV3

Quercetin Induces Cytotoxicity and Apoptosis, Reduces Metastasis and Drug Resistance in Oral Cancer Cells